Clinical Trial Update: First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of GSK3008348 in healthy volunteers and idiopathic pulmonary fibrosis patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• GSK3008348

Snippet

Sponsor: GlaxoSmithKline | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED